All In Biotech

Drug Trial Radar · NCT06451640

A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps

A Multicenter, Randomized, Ongoing Trial Evaluating the Long-term Safety and Efficacy of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps

Last checked: Nov 20, 2026Latest source record: Nov 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

59

Actual

Start

Jul 4, 2024

Primary completion

Oct 17, 2025

Study completion Oct 17, 2025

Sponsor

Sponsor type
Industry
First posted
Jun 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study aims to evaluate the efficacy and safety of TQC2731 injection in the treatment of chronic sinusitis with nasal polyps.

Conditions

  • Chronic Rhinosinusitis With Nasal Polyps

Interventions

  • 210mg of TQC2731 injectionDrug

    TQC2731 injection is a thymic stromal lymphopoietin (TSLP) monoclonal antibody.

  • 420mg of TQC2731 injectionDrug

    TQC2731 injection is a thymic stromal lymphopoietin (TSLP) monoclonal antibody.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-related adverse event rateTime frame: Up to thirty six weeks

Locations

16 sites in 1 country. Site status is shown where the registry gives one.

  • Affiliated Hospital of Zunyi Medical University

    Zunyi, Guizhou, China

  • Cangzhou Central Hospital

    Cangzhou, Hebei, China

  • Jingzhou Central Hospital

    Jingzhou, Hubei, China

  • The Third Xiangya Hospital of Central South University

    Changsha, Hunan, China

  • The First Affiliated Hospital of Suzhou University

    Suzhou, Jiangsu, China

  • The Affiliated Hospital of Xuzhou Medical University

    Xuzhou, Jiangsu, China

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

  • Affiliated Zhongshan Hospital Of Dalian university

    Dalian, Liaoning, China

  • The First Affiliated Hospital of Xi'an Jiao Tong University

    Xi'an, Shaanxi, China

  • The Afiliated Hospital Of QINGDAO University

    Qingdao, Shandong, China

  • Eye&Ent Hospital of Fudan University

    Shanghai, Shanghai Municipality, China

  • ChengDu Second People's Hospital

    Chengdu, Sichuan, China

  • West China Hospital

    Chengdu, Sichuan, China

  • Hospital of Chengdu University of TCM

    Chengdu, Sichuan, China

  • Tianjin People's Hospital

    Tianjin, Tianjin Municipality, China

  • The First Affiliated Hospital of Xinjiang Medical University

    Ürümqi, Xinjiang, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.